U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06945393) titled 'ANTIPIGMENTING OR DEPIMENTING EFFICACY UNDER PART OF VISIBLE LIGHT' on April 18.
Brief Summary: The study intends to validate a protocol and define a positive reference to evaluate the efficacy of anti-pigmenting and depigmenting agents under part of visible Light exposures, between 400nm to 450nm.
It is carried out on cosmetic products for which the safety has been assured by a toxicologist, with the aim of confirming the efficacy of the products, which will be used by a large number of consumers under normal and reasonably foreseeable use conditions.
Study Start Date: Oct. 21, 2021
Study Type: OBSERVATIONAL
Condition:
Visibl...